UPDATED Apr 17, 2024
High return on equity, past performance and sound balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CHE | US$604.17 | -2.6% | 7.8% | US$9.2b | US$688.75 | PE33.6x | E-14.2% | 0.3% | ||
3649 | JP¥1,024.00 | -5.6% | 62.8% | JP¥26.5b | n/a | PE24.8x | n/a | 1.5% | ||
EMIS | UK£19.20 | 0.1% | 2.8% | UK£1.2b | UK£19.25 | PE40.4x | E11.0% | 2.2% | ||
LNTH | US$60.25 | 0.7% | -33.4% | US$4.2b | US$93.67 | PE12.6x | E14.2% | n/a | ||
FONET | ₺25.22 | -2.5% | 652.2% | ₺3.6b | n/a | PE46.7x | n/a | n/a | ||
4771 | NT$304.50 | -8.7% | 71.5% | NT$15.4b | NT$407.00 | PE28.4x | n/a | 1.2% | ||
7807 | JP¥1,322.00 | -13.7% | 65.5% | JP¥5.6b | n/a | PE8x | n/a | 0.8% | ||
A036220 | ₩16,010.00 | -4.0% | n/a | ₩217.8b | n/a | PE1.9x | n/a | 25.0% | ||
1B1 | S$0.26 | -1.9% | -26.8% | S$40.8m | n/a | PE9.3x | n/a | 5.4% | ||
GPTHEALTH | ₹170.35 | -1.0% | n/a | ₹13.8b | n/a | PE28.7x | n/a | 2.3% | ||
1526 | HK$1.10 | 7.8% | 20.9% | HK$1.7b | n/a | PE4.4x | n/a | n/a | ||
SMLR | US$25.66 | -9.8% | 2.2% | US$182.7m | US$65.00 | PE8.8x | n/a | n/a | ||
MAITREYA | ₹149.95 | 6.0% | n/a | ₹968.0m | n/a | PE16.1x | n/a | n/a | ||
543916 | ₹149.95 | 1.6% | n/a | ₹1.5b | n/a | PE20.5x | n/a | n/a |